Professional Documents
Culture Documents
WAT E R R E S E A R C H
Available at www.sciencedirect.com
ab st rac t
Article history:
The aim of this work is to evaluate and compare the degradation achieved for three non-
29 June 2007
diclofenac (DCF), naproxen (NPX) and ibuprofen (IBP). These compounds were used in their
TiO2
degradation for NPX and IBP. However, it was observed that its rate of mineralization did
not increase. Intermediate metabolites were detected in all cases. Hydroxyl metabolites
were the most important residual compounds after the photocatalytic treatment of IBP. The
inhibition percentage of bioluminescence from Vibro fischerias a toxicity parameter
increased during the irradiation time due to the residual concentration of the hydroxyl
metabolites generated. However, after 120 min, in experiments with 40 mg/L of dissolved
oxygen, a decrease of the % inhibition was observed. Only photocatalytic treatment of IBP
drives to a satisfactory biodegradability index BOD5/COD (between 0.16 and 0.42) and, only
in this case, a post-biological treatment could be suggested.
& 2007 Elsevier Ltd. All rights reserved.
1.
Introduction
Recent studies have demonstrated the presence of pharmaceutical compounds in rivers, lakes and superficial freshwater
(Halling-Sorensen et al., 1998; Ternes, 1998; Daughton and
Ternes, 1999; Carballa et al., 2004). Non-steroidal anti-inflammatory drugs (NSAIDs) are a special group of pharmaceuticals
that are often found as a persistent toxic waste and are one of
the most widely available drugs in the world. In Spain, 55% of
the consumed Top 200 drugs are ingested orally, and approximately 5% of them correspond to NSAIDs (Takagi et al., 2006).
Some important examples of this family of medicines are
ibuprofen, naproxen, diclofenac and ketoprofen, although there
are more than 50 different types available commercially.
Corresponding author. Tel.: +34 93 402 1293; fax: +34 93 402 1291.
ARTICLE IN PRESS
586
WA T E R R E S E A R C H
2.2.
2.3.
Experimental section
2.1.
Materials
Photoreactor
3.
2.
Analytical procedures
3.1.
Previous experiments: photolysis, thermodegradation and adsorption
To avoid confusion between photocatalytic and other degradation phenomena, it was necessary to evaluate the nonphotocatalytic influence of photolysis, thermodegradation
and adsorption of each NSAID onto the TiO2 catalyst.
ARTICLE IN PRESS
WAT E R R E S E A R C H
587
Na+O-
O
O
O-Na+
O-Na+
Cl
NH
Cl
DCF
NPX
IBP
DCF
NPX
IBP
a
b
c
d
e
Flow-rate
(mL/min)a
Injection
volume (mL)
l Detection
(nm)
Temperature
(1C)
Acetonitrileb10 mM ammonium
formiatec (5050)
Acetonitrileb0.05 M ammonium
phosphate dihydrogend (8020)
Acetonitroleb0.25 acetic acide (7525)
1.25
20
280
25
1.00
20
254
25
1.75
20
254
25
ARTICLE IN PRESS
588
WA T E R R E S E A R C H
2.5
Emission spectrum
of Xe Lamp 1 kW
3
Abs (AU)
3.0
1.5
NPX
2
1
1
0.5
NSAID mM
DCF
Irradiance (W m2)
2.0
1.0
adsorbed phase
IBP
0
0
290 300 310 320 330 340 350 360 370 380 390 400
0.0
0
Wavelength (nm)
Fig. 3 Absorption spectra of DCF, NPX and IBP in Millipore
H2O and emission spectrum of Xe lamp (Allen et al., 2000).
0.2
0.4
0.6
TiO2 g/L
0.8
250
NSAID (mg/L)
DCF
NPX
IBP
200
150
100
50
0
0
30
60
90
120
150
250
DCF
NPX
IBP
TOC (mg/L)
200
150
100
50
3.2.
0
0
30
60
90
120
150
3.2.1.
rate
experiments. The pH values during the photolysis experiment
decreased from 6 to 3, but no precipitation was observed. The
acidic decrease allows us to conclude that there is an
important influence of the photolysis effect on the degradation of DCF.
To evaluate the possible degradation due to temperature, 1 L
of NSAID solution (each one separated) with a 200 ppm initial
concentration was placed in the stirred tank and heated at 20,
40, 60 and 80 1C. Once the set point temperature was reached,
an aliquot for HPLC and another one for TOC analysis were
taken. No thermo-degradation and TOC decreases were
observed for any NSAID tested in the 2080 1C range.
Concentration profiles in all cases were always constant and
Photocatalytic experiments
ARTICLE IN PRESS
WAT E R R E S E A R C H
589
Table 2 Experimental photocatalytic setup, XNSAID, XTOC, BOD5/COD and/or % Vibrio fisheri (V.f.) inhibition
NSAID
TiO2
(g/L)
Dissolved O2
(mg/L)
Flow-rate
recirculation
(L/min)
Temperature
(1C)
X
NSAID
X
TOC
BOD5/COD and/or
(% V.f. inhibition)
DCF
D1a
D2
D3
D4
D5
D6
D7
D8
D9
D10
D11
0
0.07
0.1
0.5
1
2
0.1
0.1
0.1
0.1
0.1
82b
82
82
82
82
82
82
82
82
82
40
0.2
0.2
0.2
0.2
0.2
0.2
0.1
0.4
0.2
0.2
0.2
30
30
30
30
30
30
30
30
20
40
30
0.95
0.94
0.90
0.89
0.75
0.69
0.90
0.94
0.87
0.91
0.98
0.25
0.52
0.59
0.50
0.38
0.29
0.68
0.68
0.68
0.69
0.70
0.02
o0.02
o0.02
o0.02
o0.02
o0.02
o0.02
0.02
o0.02
0.02
0.02 (14)
NPX
N1a
N2
N3
N4
N5
N6
N7
N8
N9
I1a
I2
I3
I4
I5
I6
I7
0
0.1
0.5
1
0.1
0.1
0.1
0.1
0.1
0
0.1
0.2
0.5
0.75
1
1
82
82
82
82
82
82
82
82
40
82
82
82
82
82
82
82
0.2
0.2
0.2
0.2
0.1
0.4
0.4
0.4
0.4
0.2
0.2
0.2
0.2
0.2
0.2
0.1
30
30
30
30
30
30
20
40
40
30
30
30
30
30
30
30
0.90
0.44
0.28
0.28
0.48
0.60
0.62
0.99
0.99
0.0
0.14
0.26
0.38
0.55
0.70
0.61
0.07
0.19
0.11
0.12
0.18
0.20
0.20
0.26
0.26
0.0
0.05
0.10
0.14
0.11
0.13
0.13
0.02
o0.02
o0.02
o0.02
o0.02
o0.02
o0.02
0.03
0.05 (97)
0.02
0.02
0.02
0.02
0.02
0.02
0.02
IBP
I8
I9
I10
I11
I11 (0 h)
I11 (0.5 h)
I11 (1.0 h)
I11 (2.0 h)
I11 (3.0 h)
I11 (6.0 h)
I11 (12.0 h)
I12
I12 (0.5 h)
I12 (1.0 h)
I12 (2.0 h)
I12 (3.0 h)
I13 (25 ppm)
I14 (50 ppm)
I15 (100 ppm)
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
82
82
82
40
40
40
40
40
40
40
40
8
8
8
8
8
40
40
40
0.4
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
30
20
40
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
0.71
0.65
0.79
0.99
0
0.19
0.21
0.59
0.70
0.99
0.99
0.68
0.20
0.28
0.33
0.49
0.99
0.99
0.99
0.18
0.13
0.15
0.14
0
0.05
0.11
0.14
0.15
0.16
0.17
0.14
0.03
0.06
0.10
0.12
0.80
0.74
0.50
0.02
0.02
0.02
0.16 (87)
0 (77)
(79)
0.03 (82)
0.10 (91)
(88)
0.20
0.29
0.04 (79)
0.04 (89)
0.04 (87)
0.04 (78)
0.04 (84)
0.42
0.30
0.19
3.2.2.
ARTICLE IN PRESS
590
WA T E R R E S E A R C H
1
DCF
NPX
IBP
NSAID/NSAIDo
0.8
0.6
0.4
0.2
0
0
50
100
150
200
Irradiation time (min)
250
300
TiO2 (g/L)
K (min1)
0.1
0.1
1.0
9.6 103
7.0 103
9.1 103
ARTICLE IN PRESS
WAT E R R E S E A R C H
1.00
200
25 ppm
50 ppm
100 ppm
200 ppm
25 ppm
50 ppm
100 ppm
200 ppm
0.75
X TOC
150
IBP ppm
591
100
0.50
0.25
50
0.00
0
50
100
150
Irradiation Time (min)
200
250
50
100
150
Irradiation Time (min)
200
250
Fig. 7 (a) Initial IBP concentration effect on IBP removal. (b) Initial IBP concentration effect on XTOC.
0.5
0.4
0.4
0.3
BOD5/COD
BOD5/COD
0.3
0.2
0.2
0.1
0.1
0
1 hr
0
25 ppm
50 ppm
100 ppm
IBP initial concentration
200 ppm
2 hr
4 hr
6 hr
Irradiation Time
12 hr
0.4
0.5
X IBP
0.75
0.3
0.5
0.2
0.25
X TOC
0.4
BOD5/COD
0.3
0.2
0.1
0
8-2 (free
consume)
0.1
8 g/L (O2 eq
AIR)
40 g/L (O2
SAT)
Oxygen concentration
0
0
0
60
120
180
240
3.2.5.
ARTICLE IN PRESS
592
WA T E R R E S E A R C H
O
HO
O
O-
OH
O-
H
O-
OH
[205]
I
OH
O
O-
HO
O
[221]
HO II
O-
O[221]
III
OO
HO
OH
[162]
O
H 3C
O-
C 2H 5
OH
[221] HO
[178]
HO
OH
[178]
O-
OH H3C
[133]
O
OH
OH
O
OH
IV
[238] HO
Fig. 12 Intermediates observed at the end of photocatalytic treatment of IBP. [IBP]o 200 ppm, 1 g/L TiO2, 40 mg/L O2, 4 h
irradiation time.
20
95
85
80
10
75
5
% inhibition Vib.fisch.
90
15
EC50 (%v/v)
70
0
65
0
30
60
120
180
Irradiation Time (min)
240
ARTICLE IN PRESS
WAT E R R E S E A R C H
4.
Conclusions
593
Acknowledgments
The authors would like to thank the financial support from
the Spanish Ministry of Education and Science (Projects
CTQ2005-00446/PPQ and CTQ2004-02311/PPQ), the Barcelona
University for the predoctoral grant, Marc Esplugas for his
help in the management of the research and to Dr. Marta
Vilaseca Casas and Dr. Mara Reixach Riba for their help and
technical support in the HPLC and LCMS analyses.
R E F E R E N C E S
ARTICLE IN PRESS
594
WA T E R R E S E A R C H
Stumpf, M., Ternes, T., Harbere, K., Baumann, W., 1998. Isolierung
von Ibuprofen-Metaboliten und deren Bedeutung als Kontaminanten der aquatischen Umwelt. Vom Wasser 91,
291303.
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L.,
Amidon, G., 2006. A provisional biopharmaceutical classification of the top 200 drug products in the United States, Great
Britain, Spain and Japan. Mol. Pharm. 3 (6), 631643.
Ternes, T., 1998. Occurrence of drugs in German sewage
treatments plants and rivers. Water Res. 32 (11), 32453260.
Ternes, T., 2003. Ozonation: a tool for removal of pharmaceuticals,
contrast media and fragrances from wastewater? Water Res.
37, 19761982.
Tixier, C., Singer, H., Oellers, S., Muller, S., 2003. Ocurrence and
fate of carbamazepine, ibuprofen, ketoprofen and naproxen in
surface waters. Environ. Sci. Technol. 37 (6), 10611068.
Weigel, S., Berger, U., Jensen, E., Kallenborn, R., Thoresen, H.,
Huhnerfuss, H., 2004. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromso/
Norway whit emphasis on ibuprofen and its metabolites.
Chemosphere 56, 583592.
Zweiner, C., 2000. Oxidative treatment of pharmaceuticals in
water. Water Res. 34, 18811885.
Zweiner, C., Seeger, S., Glauner, T., Frimmel, F., 2002. Metabolites
from the biodegradation of pharmaceuticals residues of
ibuprofen in biofilm reactors and batch experiments. Anal.
Bioanal. Chem. 372, 569575.